Clinical Trials
158 trialsAdaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma
Nanfang Hospital, Southern Medical University
AI-Based Risk Prediction Model for Upper Digestive Tract Cancer
National Taiwan University Hospital
A Subharmonic-Aided Pressure Estimate Technology for Prediction of Response to Systemic Therapy in Gastric Cancer Liver Metastases
The First Hospital of Jilin University
Iparomlimab Tolvorlimab as Neoadjuvant Immunotherapy for Locally Advanced Gastric Adenocarcinoma With Microsatellite Instability/Mismatch Repair Deficiency
Peking University Cancer Hospital & Institute
Evaluation of Fecal Multi-target Biomarkers in the Screening of Digestive Tract Cancers
Xijing Hospital
SUNRISE
AdventHealth Translational Research Institute
BBNIGC
Nanfang Hospital, Southern Medical University
GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer
University of Illinois at Chicago
ChefHat-001
BigHat Biosciences, Inc.
PREDIPER
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Window Of Opportunity Study Of TROP2 CAR/IL-15 TGFBR2 KO NK Cells Delivered Intraperitoneally For The Management Of Gastric Cancer Metastatic To The Peritoneum
M.D. Anderson Cancer Center
SIGNAL GEC-101
Natera, Inc.
MRinRT
Swansea Bay University Health Board
Non-Invasive Detection of claudin18.2 in Pancreatic and Gastric/Gastroesophageal Junction Cancer by [68Ga]Ga-NODAGA-SNA014 PET Imaging
Ruijin Hospital
FREEDOM
Harbin Medical University
A Study Comparing BL-M05D1 With the Investigator's Choice of Treatment Regimen in Patients With Claudin (CLDN)18.2-Positive Advanced Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GC/GEJC) Who Have Received Prior First-Line Treatment
Sichuan Baili Pharmaceutical Co., Ltd.
Efficacy of Sintilimab Combined With Bevacizumab and XELOX/SOX in Initially Unresectable AFP-positive Gastric/Gastroesophageal Junction Adenocarcinoma
Fudan University
18F-FAPI PET/CT and MRI in Gastric Cancer
First Affiliated Hospital of Zhejiang University
pCLE
Changhai Hospital
Dynamic ctDNA-Guided Adjuvant Therapy in cStage III and IVA Gastric or Gastroesophageal Junction Adenocarcinoma
Fudan University
TNT-SHORT
Washington University School of Medicine
A Clinical Study of Iparomlimab and Tuvonralimab Combined With SOX Following Heterogeneous Radiotherapy as First-line Treatment for Unresectable Locally Advanced or Metastatic HER2-negative Gastric or Gastroesophageal Junction Adenocarcinoma
Huazhong University of Science and Technology
Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing
LanZhou University
IND-PREP
Asian Institute of Gastroenterology, India
REPROG-RCT
Yonsei University
QLS5132 Combination Therapy in Advanced Solid Tumors
Qilu Pharmaceutical Co., Ltd.
TAP-WELPASS
Pusan National University Yangsan Hospital
A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression
Convalife (Shanghai) Co., Ltd.
Full-time RDI for ESD: Impact on Major Adverse Events and Procedure Time
Xijing Hospital of Digestive Diseases
Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial
Fudan University
Megestrol Acetate Oral Suspension for Cachexia in Patients With cStage III Gastric/Gastroesophageal Junction Adenocarcinoma Receiving Neoadjuvant Therapy With Serplulimab Combined With SOX
The First Affiliated Hospital with Nanjing Medical University
Huaxi
Sichuan University
To Evaluate the Safety and Tolerability of Study Drug as a Third-line and Beyond Therapy for Recurrent or Metastatic Gastric Cancer
Onconic Therapeutics Inc.
First in Human Study of QLS5316 in Solid Tumors
Qilu Pharmaceutical Co., Ltd.
Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy
The First Affiliated Hospital with Nanjing Medical University
SL-28 for Advanced Solid Tumours
Second Life Therapeutics
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
The Application of Extracellular Vesicle Detection in Gastric Juice Based on Metamaterial Sensing in the Diagnosis of Gastric Cancer and Related Diseases
Beijing Friendship Hospital
A Hypoxia-Inducible CAR-T Cell Targeting AXL and CD73 for Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Clinical Study to Evaluate the Safety and Anti-Tumor Activity of AB-201
Yonsei University
NEOTOGAS
Nantes University Hospital
SOP-XH-IRB
Fujian Medical University
RAGIP
LanZhou University
QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
The First Affiliated Hospital with Nanjing Medical University
Co-SNARE
Region Stockholm
Combination of Osemitamab (TST001), Pembrolizumab and Chemotherapy as First-line Therapy in Advanced or Metastatic GC/GEJ Adenocarcinoma
Suzhou Transcenta Therapeutics Co., Ltd.
Novel Humanized Ferritin-based NIR Fluorescent Molecular Probe for Identifying Tumor Margins in Gastric Tissue
Nanfang Hospital, Southern Medical University
IMRD
European Institute of Oncology
The Efficacy and Safety of Laparoscopic Proximal Gastrectomy With LPG-tbROSF Versus LTG for Localized Proximal Gastric Cancer.
First Affiliated Hospital of Wenzhou Medical University
Single-port Robotic Radical Gastrectomy for Gastric Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University